Literature DB >> 8954175

Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype.

B He1, Z Y Tang, K D Liu, G Zhou.   

Abstract

The polymerase chain reaction and HaeIII enzymatic digestion were used to study the seventh exon of the p53 gene in 29 primary and recurrent hepatomas in paraffin-embedded samples from 11 patients. The mutation rate of the p53 gene and its genotypes in samples of primary and recurrent tumours and multiple nodules were investigated. The cellular origins of hepatocellular carcinoma were analysed by p53 genotype. p53 mutation rates were found to be 69.0% (20/29) in the primary and recurrent tumours, 58.8% (10/17) in tumours with a single nodule and 83.3% (10/12) in tumours with multiple nodules. The p53 genotypes were found to be different in 6 pairs of primary and recurrent tumours, and another 5 pairs had the same p53 genotypes. The samples with multiple nodules in the same patients had the same p53 genotypes. Seven recurrences were of multicentric origin and four were of unicentric origin. It is suggested that the recurrent lesions developed from both unicentric and multicentric origins.

Entities:  

Mesh:

Year:  1996        PMID: 8954175     DOI: 10.1007/bf01209125

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

Review 1.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  Hepatocellular carcinoma mutation.

Authors:  N K Hayward; G J Walker; W Graham; E Cooksley
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

3.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.

Authors:  B Bressac; M Kew; J Wands; M Ozturk
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

4.  Clonal origin of recurrent hepatocellular carcinomas.

Authors:  P J Chen; D S Chen; M Y Lai; M H Chang; G T Huang; P M Yang; J C Sheu; S C Lee; H C Hsu; J L Sung
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

5.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

Review 6.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

7.  Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.

Authors:  N Nishida; Y Fukuda; H Kokuryu; J Toguchida; D W Yandell; M Ikenega; H Imura; K Ishizaki
Journal:  Cancer Res       Date:  1993-01-15       Impact factor: 12.701

8.  Resection of hepatocellular carcinoma: oligocentric origin of recurrent and multinodular tumours.

Authors:  X H Liang; I F Loncarevic; Z Y Tang; Y Q Yu; H Zentgraf; C H Schröder
Journal:  J Gastroenterol Hepatol       Date:  1991 Jan-Feb       Impact factor: 4.029

9.  Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.

Authors:  Y Murakami; K Hayashi; S Hirohashi; T Sekiya
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

10.  Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients.

Authors:  H C Hsu; S Y Peng; P L Lai; J C Sheu; D S Chen; L I Lin; B L Slagle; J S Butel
Journal:  Cancer       Date:  1994-01-01       Impact factor: 6.860

View more
  2 in total

Review 1.  Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.

Authors:  Hui-Chuan Sun; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

Review 2.  A decade's studies on metastasis of hepatocellular carcinoma.

Authors:  Zhao-You Tang; Sheng-Long Ye; Yin-Kun Liu; Lun-Xiu Qin; Hui-Chuan Sun; Qin-Hai Ye; Lu Wang; Jian Zhou; Shuang-Jian Qiu; Yan Li; Xue-Ning Ji; Hu Liu; Jing-Ling Xia; Zhi-Quan Wu; Jia Fan; Zeng-Chen Ma; Xin-Da Zhou; Zhi-Ying Lin; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-18       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.